Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Spastic Cerebral Palsy Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 45
Abbreviations 45
Definitions 45
Research Methodology 46
Secondary Research 46
About GlobalData 47
Contact Us 47
Disclaimer 47
Source 47

List of Tables
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Region, 2018* 6
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Spastic Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
Spastic Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
Spastic Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
Spastic Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 15
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 18
Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase, 2018* 21
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Spastic Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List of Figures
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Spastic Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
Spastic Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
Spastic Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
Spastic Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 14
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 18
Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Spastic Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
GlobalData Methodology 46

Companies Mentioned
- Ipsen SA
- Daiichi Sankyo Co Ltd
- Medy-Tox Inc
- Medtronic Plc
- iCELL Biotechnology Co Ltd
- Hugel Inc
- GlaxoSmithKline Plc